Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT03452774 is registered in ClinicalTrials.gov with Massive Bio, Inc. as lead sponsor.

NCT NCT03452774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03452774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Lead sponsor
Massive Bio, Inc.
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2018
Completion date
June 30, 2040
Enrollment
50,000 (estimated)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, brca gene rearrangement, breast cancer, cancer, cancer liver, cancer of cervix, cancer of colon, cancer of esophagus, cancer of kidney, cancer of larynx, cancer of liver, cancer of neck, cancer of pancreas, cancer of rectum, cancer of skin, cancer of stomach, cancer prostate, cancer, advanced, cancer, breast, cancer, lung, cancer, metastatic, carcinoma, central nervous system tumor, cholangiocarcinoma, covid, endometrial cancer, follicular lymphoma, glioblastoma, leukemia, mantle cell lymphoma, marginal zone lymphoma, melanoma, mismatch repair deficiency, myelodysplastic syndromes, myelofibrosis, myeloproliferative disorders, myeloproliferative neoplasm, neuroendocrine tumors, non hodgkin lymphoma, non small cell lung cancer, ovarian cancer, testicular cancer, urothelial carcinoma